A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.
A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.
Recruiting · NCT06182969 · Registry updated 2025-12-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus. | systemic lupus erythematosus | Recruiting | Phase 1 / Phase 2 | 2025-12-16 | NCT06182969 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ascentage Pharma Group Inc. | 30 |
| Suzhou Yasheng Pharmaceutical Co., Ltd. | 8 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Renji Hospital Shanghai Jiaotong University School of Medical | Shanghai | China | 1 |